Prokineticin R2/PROKR2 Products

Antibodies
Prokineticin R2/PROKR2 Antibo ...
Prokineticin R2/PROKR2 Antibody
NBP1-92290
Species: Hu
Applications: IHC, IHC-P
Host: Rabbit Polyclonal
Prokineticin R2/PROKR2 Antibo ...
Prokineticin R2/PROKR2 Antibody
NLS3155
Species: Hu, Mk, Pm
Applications: IHC-P
Host: Rabbit Polyclonal
Prokineticin R2/PROKR2 Antibo ...
Prokineticin R2/PROKR2 Antibody
NBP1-45218
Species: Hu, Rt
Applications: WB, PEP-ELISA
Host: Goat Polyclonal
Proteins
Prokineticin R2/PROKR2 Recomb ...
Prokineticin R2/PROKR2 Recombinant...
NBP1-92290PEP
Species: Hu
Applications: AC
RNAi
Prokineticin R2/PROKR2 RNAi
Prokineticin R2/PROKR2 RNAi
H00128674-R02
Species: Hu
Applications: RNAi, RNAi SP

Description

Corticotropin Releasing Factor Receptor 2 (CRHR2) expression has been reported in various regions of the brain, as well as in placenta, umbilical vein, heart, epididymis, gastrointestinal tract, adrenal, and skeletal muscle. It shows high-affinity CRF binding and also binds to urocortin I, II and III. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. CRCH2 alpha is the dominant isoform and is expressed widely. CRCH2 beta is expressed in the hippocampus, septum, amygdala, heart, and skeletal muscle. CRHR2 gamma is brain-specific. ESTs have been isolated from brain libraries.

Bioinformatics

Entrez Human
Rat
Uniprot Human
Product By Gene ID 128674
Alternate Names
  • dJ680N4.3
  • GPR73L1Kallmann syndrome 3 (autosomal dominant)
  • GPRg2KAL3
  • GPR73bG-protein coupled receptor 73-like 1
  • PKR2PK-R2
  • G protein-coupled receptor 73-like 1
  • prokineticin receptor 2

Research Areas for Prokineticin R2/PROKR2

Find related products by research area and learn more about each of the different research areas below.

Protein Phosphatase

Bioinformatics Tool for Prokineticin R2/PROKR2

Discover related pathways, diseases and genes to Prokineticin R2/PROKR2. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.